• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.

广告
作者单位: Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. [1] Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany. [2] Department of Molecular and Cellular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany. [3] Department for Molecular and Cellular Sports Medicine, German Sport University Cologne, Cologne, Germany. [4] Gipuzkoa Cancer Unit, OSID-Onkologikoa, BioGipuzkoa, Osakidetza, San Sebastian, Spain. [5] Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia. [6] Department of Laboratory Medicine, Karolinska Institutet and Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden. [7] Working Group Exercise Oncology, Division of Medical Oncology, Heidelberg University Hospital and NCT Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany. [8] Heidelberg University Hospital and NCT Heidelberg, A Partnership Between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany. [9] Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, the Netherlands. [10] National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany. [11] Department of Oncology-Pathology, Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden. [12] Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. [13] Breast Cancer Center, Netherlands Cancer Institute, Amsterdam, the Netherlands. [14] Royal Melbourne Hospital, Melbourne, Victoria, Australia. [15] Peter MacCallum Cancer Center, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. [16] Cabrini Cancer Institute, Cabrini Health, Melbourne, Victoria, Australia. [17] University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Gynecology and Obstetrics, Breast Center, CIO. [18] Greater Poland Cancer Centre, Poznan, Poland. [19] Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. [20] Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. [21] Cabrini Cancer Institute, Cabrini Health, Melbourne, Victoria, Australia.;Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia. [22] Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden. [23]
DOI 10.1200/JCO-24-01441
PMID 39805062
发布时间 2025-01-13
提交
  • 浏览0

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷